欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7753/001
药品名称Raltegravir Lupin 600 mg filmtabletten
活性成分
    • RALTEGRAVIR potassium 600.0 mg
剂型Film-coated tablet
上市许可持有人Lupin Europe GmbH Hanauer Landstrasse 139-143 60314 Frankfurt Am Main Germany
参考成员国 - 产品名称Germany (DE)
Raltegravir Lupin 600 mg Filmtabletten
互认成员国 - 产品名称
    • Finland (FI)
    • France (FR)
    • Italy (IT)
    • Latvia (LV)
    • Lithuania (LT)
      Raltegravir Lupin 600mg plėvele dengtos tabletės
    • Netherlands (NL)
    • Norway (NO)
    • Portugal (PT)
    • Bulgaria (BG)
      Raltegravir Lupin
    • Romania (RO)
      Raltegravir Lupin 600mg film‐coated tablets
    • Czechia (CZ)
      Raltegravir Lupin 600mg film‐coated tablets
    • Slovenia (SI)
    • Denmark (DK)
    • Sweden (SE)
    • Estonia (EE)
    • Spain (ES)
许可日期2024/07/24
最近更新日期2024/09/27
药物ATC编码
    • J05AJ01 raltegravir
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase